Pemphigus vs Pemphigoid

Introduction

Autoimmune vesiculobullous diseases are a significant topic in Oral Pathology for the NEET MDS exam. Among these, Pemphigus and Pemphigoid are frequently confused due to similar clinical presentations, but they have distinct underlying pathologies, histopathologies, and immunofluorescence (IF) patterns. Understanding these differences is crucial for diagnosis and treatment. This guide will provide a comprehensive, exam-focused comparison.

Pemphigus

Definition

Pemphigus refers to a group of chronic, potentially life-threatening autoimmune mucocutaneous diseases characterized by the formation of intraepithelial blisters in the skin and/or mucous membranes. This is due to a loss of cell-to-cell adhesion (acantholysis) of keratinocytes.

Classification/Types

• Pemphigus Vulgaris (PV): The most common form, accounting for about 70% of all pemphigus cases. Oral lesions are often the first sign.
• Pemphigus Vegetans: A milder variant of PV, characterized by hypertrophic, vegetating lesions.
• Pemphigus Foliaceus: More superficial blistering, often without oral involvement.
• Pemphigus Erythematosus: A localized form with features of both pemphigus foliaceus and lupus erythematosus.
• Paraneoplastic Pemphigus: Associated with underlying neoplasms, often more severe and resistant to treatment.

Clinical Features

• Oral Lesions: Often the initial manifestation (up to 80% of PV cases). Lesions are typically painful, chronic, irregular erosions with ragged margins, frequently seen on the buccal mucosa, palate, and gingiva. Intact bullae are rarely seen as they rupture quickly. ⭐Desquamative gingivitis is a common presentation.
• Skin Lesions: Flaccid bullae that rupture easily, leaving widespread erosions and crusts. Lesions are non-scarring.
• Other Mucosal Sites: Pharynx, larynx, esophagus, conjunctiva, anogenital regions can be affected.
• ⭐Nikolsky Sign: Positive. This means that gentle lateral pressure on seemingly normal skin or mucosa causes the superficial layers to slough off, forming a new blister or erosion.
• Lack of Scarring: Lesions heal without scar formation, though post-inflammatory hyperpigmentation may occur.

Histopathology & Immunofluorescence (IF)

• ⭐Acantholysis: The hallmark feature, characterized by the loss of cohesion between keratinocytes.
• ⭐INTRAEPITHELIAL Blister Formation: The blister forms within the epithelial layer. In Pemphigus Vulgaris, this is typically a suprabasal split, meaning the basal layer of keratinocytes remains attached to the basement membrane, forming a 'tombstone' appearance.
• Tombstone Cells: Basal cells remaining attached to the basement membrane, resembling tombstones.
• ⭐Tzanck Cells: On a cytological smear (Tzanck smear) from an intact blister, these are free-floating, rounded-up acantholytic keratinocytes with large, hyperchromatic nuclei and prominent nucleoli. ⭐Presence of Tzanck cells is highly suggestive of pemphigus.
• ⭐Direct Immunofluorescence (DIF): Considered the gold standard for diagnosis. Shows a characteristic ⭐'fishnet' or 'chicken-wire' pattern of IgG (and often C3) deposition in the intercellular spaces of the epithelium, outlining the keratinocytes.
• Indirect Immunofluorescence (IIF): Detects circulating autoantibodies in the patient's serum. These antibodies target desmoglein 1 and/or desmoglein 3, which are components of desmosomes.

Pemphigoid (Mucous Membrane Pemphigoid / MMP)

Definition

Pemphigoid refers to a group of chronic autoimmune mucocutaneous diseases characterized by the formation of subepithelial blisters. The primary target of the autoimmune attack is components of the basement membrane zone (BMZ), leading to separation of the epithelium from the underlying connective tissue.

Classification/Types (Focus on Oral Relevance)

• Mucous Membrane Pemphigoid (MMP): Previously known as Cicatricial Pemphigoid. Primarily affects mucous membranes, with the oral cavity being the most common site. Ocular involvement is a serious concern.
• Bullous Pemphigoid (BP): Primarily affects the skin, usually in older individuals. Oral lesions are less common (10-40%) and less severe than in MMP or Pemphigus.
• Linear IgA Disease: Characterized by linear IgA deposition at the BMZ.
• Epidermolysis Bullosa Acquisita: Autoimmune disease targeting type VII collagen.

Clinical Features

• Oral Lesions: Most common site for MMP. Lesions are chronic, painful erosions, often presenting as ⭐desquamative gingivitis. Intact, tense bullae may be seen but are less common than ruptured erosions. Bullae are more resilient and last longer than in pemphigus.
• Ocular Lesions: A critical feature of MMP. Can lead to conjunctival scarring, symblepharon (adhesion between bulbar and palpebral conjunctiva), and potentially blindness if untreated. ⭐Ocular consultation is mandatory for MMP patients.
• Skin Lesions: Less common in MMP, but when present, manifest as tense bullae, often on the trunk and extremities. These heal with scarring. In Bullous Pemphigoid, tense bullae are the predominant feature.
• Other Mucosal Sites: Nasopharynx, esophagus, larynx, genitalia can be involved, potentially leading to strictures.
• ⭐Nikolsky Sign: Positive, but less readily elicited and less dramatic than in pemphigus, as the split is deeper.
• Healing with Scarring: A key differentiator. Lesions, especially ocular and laryngeal, heal with scar formation due to the deeper tissue damage.

Histopathology & Immunofluorescence (IF)

• ⭐SUBEPITHELIAL Blister Formation: The hallmark feature. The entire epithelial layer separates from the underlying connective tissue at the basement membrane zone.
• Intact Epithelium: The roof of the blister consists of the full thickness of the epithelium, which is why the bullae are tense and more resistant to rupture.
• Inflammatory Infiltrate: Often present in the connective tissue beneath the blister, consisting of lymphocytes, plasma cells, and sometimes eosinophils (especially prominent in Bullous Pemphigoid).
• ⭐Direct Immunofluorescence (DIF): Shows a characteristic ⭐continuous LINEAR band of IgG (and/or IgA, C3) deposition along the basement membrane zone (BMZ).
• Indirect Immunofluorescence (IIF): Detects circulating autoantibodies, which target various components of the hemidesmosomes (e.g., BPAG1, BPAG2, laminin 332, type VII collagen).

Differential Diagnosis & Key Comparisons

Understanding the distinctions is vital for NEET MDS.

• Blister Location:
  ⭐Pemphigus: INTRAEPITHELIAL (within the epithelium, suprabasal split in PV).
  ⭐Pemphigoid: SUBEPITHELIAL (below the epithelium, at the BMZ).
• Autoantigen Target:
  ⭐Pemphigus: Desmogleins (components of desmosomes, responsible for cell-to-cell adhesion).
  ⭐Pemphigoid: Hemidesmosomal proteins (e.g., BPAG1, BPAG2, laminin 332, type VII collagen, responsible for epithelial-connective tissue adhesion).
• Immunofluorescence Pattern (DIF):
  ⭐Pemphigus: 'Fishnet' or 'chicken-wire' pattern of IgG/C3 in intercellular spaces.
  ⭐Pemphigoid: Continuous LINEAR band of IgG/C3 along the basement membrane zone.
• Tzanck Cells:
  ⭐Pemphigus: Present (acantholytic keratinocytes).
  Pemphigoid: Absent.
• Bullae Characteristics:
  Pemphigus: Flaccid, rupture easily, rarely seen intact.
  Pemphigoid: Tense, more resistant to rupture, may be seen intact.
• Healing:
  Pemphigus: Heals without scarring.
  ⭐Pemphigoid: Heals with scarring (especially ocular and laryngeal lesions).
• Nikolsky Sign:
  ⭐Pemphigus: Positive and readily elicited.
  ⭐Pemphigoid: Positive but less readily elicited.
• Prognosis: Pemphigus generally has a more guarded prognosis due to widespread disease and potential for systemic complications. MMP, while not usually life-threatening, can cause significant morbidity (e.g., blindness).

Other Differential Diagnoses: Erosive Lichen Planus, Erythema Multiforme, Recurrent Aphthous Stomatitis, Lupus Erythematosus, Epidermolysis Bullosa.

Treatment

General Principles

Treatment for both conditions involves suppressing the immune system to halt blister formation and promote healing. This typically involves:

• Systemic Corticosteroids: The mainstay of treatment (e.g., Prednisone). Higher doses are usually required for pemphigus initially.
• Immunosuppressants/Corticosteroid-Sparing Agents: To reduce steroid dosage and side effects (e.g., Azathioprine, Mycophenolate Mofetil, Cyclophosphamide, Methotrexate).
• Rituximab: An anti-CD20 monoclonal antibody, increasingly used for severe or refractory cases, particularly pemphigus.
• Topical Corticosteroids: For localized oral lesions (e.g., Clobetasol propionate, Fluocinonide).
• Supportive Care: Pain management, meticulous oral hygiene, antibiotics for secondary infections, nutritional support.

Pemphigus Specifics

Requires aggressive initial systemic corticosteroid therapy due to its potentially life-threatening nature. Long-term maintenance therapy is often necessary.

Pemphigoid Specifics

Milder cases may be managed with dapsone, tetracycline with niacinamide, or topical/intralesional steroids. Severe or rapidly progressing cases, especially with ocular involvement, require systemic corticosteroids and immunosuppressants. ⭐Regular ophthalmological evaluation is crucial for MMP patients.

Exam Tips for NEET MDS

• ⭐Memorize the core distinction: Pemphigus = INTRAEPITHELIAL, Pemphigoid = SUBEPITHELIAL.
• ⭐Associate Pemphigus with 'fishnet' IgG and Tzanck cells.
• ⭐Associate Pemphigoid with 'linear' IgG at the BMZ and scarring.
• Understand that ⭐Nikolsky sign is positive in BOTH, but more prominent in Pemphigus.
• Know the specific autoantigens: ⭐Desmogleins for Pemphigus, Hemidesmosomal proteins for Pemphigoid.
• Recognize the clinical presentation nuances: flaccid bullae/non-scarring for pemphigus, tense bullae/scarring (especially ocular) for pemphigoid.
• DIF is the diagnostic gold standard for both.
• Be aware of the initial treatment approach (systemic steroids) and the role of adjunctive therapies.